Can a melatonin pill protect the body from the damage of working nights?
Maybe. In this small randomized trial, melatonin supplementation was linked to a 1.8-fold increase in a marker of DNA repair while night shift workers slept during the day. The result was borderline, but it points to a simple way to fight a known health risk of overnight work.
Working nights does more than make you tired. It scrambles your body clock and shuts down melatonin, the hormone you normally make in the dark. Melatonin does more than help you sleep. It also helps your cells clean up damage to your DNA. When night work suppresses melatonin, that cleanup may slow down, and over time that damage is thought to raise the risk of cancer. This study asked a direct question: if night workers take melatonin, can they restore some of that lost repair ability?
What the researchers measured
Your cells are constantly under attack from a process called oxidative stress, which can nick and damage DNA. Normally your body finds these damaged spots, snips them out, and flushes the broken pieces into your urine. One of those broken pieces is a molecule called 8-hydroxy-2’-deoxyguanosine, or 8-OH-dG for short. A higher amount of it in urine actually signals good news here. It means the body is finding and removing damage rather than leaving it in place. So researchers used 8-OH-dG levels as a window into how well DNA repair was working.
What the data show
This was a randomized, placebo-controlled trial, the gold standard for testing a treatment. Forty night shift workers were split into two groups. One group took 3 mg of melatonin about an hour before their daytime sleep, and the other took a dummy pill. They followed this routine for four weeks. The team collected all the urine each person made during a typical day sleep and a typical night shift, both before and during the study.
The standout result came during day sleep. The melatonin group showed a 1.8-fold rise in urinary 8-OH-dG, suggesting their bodies were repairing DNA damage more actively. That said, the finding was borderline, with a 95% confidence interval of 1.0 to 3.2 and a p-value of 0.06, which sits just outside the usual cutoff for statistical certainty. During the night shift itself, melatonin made no real difference, with excretion levels nearly identical between the two groups.
Dr. Kumar’s Take
I find this study genuinely interesting because it goes after a real mechanism, not just a vague hope. We have long suspected that suppressed melatonin is part of why night work is tied to cancer, and this trial tries to close that loop with a cheap, widely available supplement. The effect during day sleep is encouraging. But I want to be honest with you. With only 40 people and a p-value of 0.06, this is a signal, not a verdict. It tells me the idea deserves a bigger, longer trial, not that everyone working nights should start taking melatonin tomorrow. I treat it as a promising lead.
Who this might help
The people most likely to care about these findings are those who work overnight shifts on a regular basis, such as nurses, factory workers, drivers, and emergency responders. These are the same groups that research has long flagged as facing a modestly higher cancer risk. The trial focused specifically on the daytime sleep window, which is exactly when a night worker’s body is fighting against its own clock. The fact that melatonin’s benefit showed up during day sleep, and not during the night shift, fits that picture neatly.
Limits worth knowing
This was a small study, and the main result was borderline rather than rock solid. It measured a marker of DNA repair, not actual cancer rates, so we cannot say it prevents disease. We only know it nudged a biological signal in a helpful direction. The authors themselves call for larger trials that test different doses and track people over longer periods. Melatonin is also not risk-free for everyone, and the right dose and timing can vary from person to person.
Practical Takeaways
- If you work night shifts, talk to your doctor before starting melatonin, since the right dose and timing depend on your schedule and health.
- The workers in this trial took 3 mg about an hour before their daytime sleep, which is a modest, common dose rather than a megadose.
- Treat melatonin as one possible tool, not a cure, and keep up proven habits like a dark, quiet sleep space and a consistent sleep routine.
- Remember this study measured a marker of DNA repair, not cancer itself, so view it as early evidence rather than a guarantee.
Related Studies and Research
- One night of sleep loss increases Alzheimer’s protein in spinal fluid
- Long daytime naps linked to higher death risk in older adults
- Mindfulness meditation for chronic insomnia: randomized controlled trial results
- Protein before sleep increases overnight muscle protein synthesis in older men
FAQs
Does melatonin actually prevent cancer in night shift workers?
We cannot say that yet. This trial measured 8-OH-dG, a urine marker that reflects how well the body repairs DNA damage, not the number of cancer cases. A rise in this marker suggests the repair system is working harder, which is a plausible step in lowering risk. But measuring better repair is not the same as proving fewer cancers. Proving that would take a much larger study following workers for many years.
How much melatonin did the workers take, and when?
Participants in the melatonin group took 3 mg roughly one hour before they went to sleep during the day. This timing matters because a night worker’s main sleep happens when the body would normally be awake and exposed to light. Taking melatonin before day sleep is meant to mimic the natural hormone surge that night work suppresses. The 3 mg dose is on the lower, more common end of what is sold over the counter.
Why was the result called borderline instead of definitive?
The increase in DNA repair marker had a p-value of 0.06, which sits just above the standard 0.05 threshold scientists use to call a result statistically significant. The confidence interval also stretched from 1.0 to 3.2, meaning the true effect could be anywhere from essentially none to quite large. With only 40 people in the study, there was not enough data to pin the answer down tightly. That is why the authors call for bigger trials before drawing firm conclusions.
Bottom Line
Night shift work suppresses melatonin and appears to weaken the body’s ability to repair DNA, which may help explain its link to cancer. In this small randomized trial, taking 3 mg of melatonin before day sleep was associated with a 1.8-fold rise in a marker of DNA repair, though the result was borderline. It is an encouraging early signal that a simple supplement might help offset one of the hidden costs of working nights, but larger and longer studies are needed before it becomes a recommendation.
